Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Michael A. Henderson
HDAC Inhibitor Panobinostat Engages Host Innate Immune Defenses to Promote the Tumoricidal Effects of Trastuzumab in HER2 + Tumors
Cancer Research
Cancer Research
Oncology
High Mammographic Density in Women Is Associated With Protumor Inflammation
Breast Cancer Research
Cancer Research
Oncology
Related publications
Salmonella Exploits NLRP12-dependent Innate Immune Signaling to Suppress Host Defenses During Infection
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
The HDAC Inhibitor LBH589 (Panobinostat) Is an Inhibitory Modulator of Aromatase Gene Expression
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Host Histone Acetylation Unlocks HDAC Inhibitor Potential
Oncotarget
Oncology
Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
Cell Host and Microbe
Immunology
Molecular Biology
Cancer Research
Virology
Microbiology
Microbiology
Parasitology
Dengue Virus and the Host Innate Immune Response
Emerging Microbes and Infections
Immunology
Virology
Microbiology
Epidemiology
Parasitology
Medicine
Drug Discovery
Infectious Diseases
The HDAC Inhibitor LBH589 Enhances the Antimyeloma Effects of the IGF-1RTK Inhibitor Picropodophyllin
Clinical Cancer Research
Cancer Research
Oncology
Inhibitors of HSP90 Block P95-Her2 Signaling in Trastuzumab-Resistant Tumors and Suppress Their Growth
Oncogene
Cancer Research
Genetics
Molecular Biology
HDAC Inhibitor, CG-745, Enhances the Anti-Cancer Effect of Anti-Pd-1 Immune Checkpoint Inhibitor by Modulation of the Immune Microenvironment
Journal of Cancer
Oncology
Cytokeratin 5/6 Fingerprinting in HER2-positive Tumors Identifies a Poor Prognosis and Trastuzumab-Resistant Basal-Her2 Subtype of Breast Cancer
Oncotarget
Oncology